Login / Signup

Activation of miR-500a-3p/CDK6 axis suppresses aerobic glycolysis and colorectal cancer progression.

Yu LiuWentao TangLi RenTianyu LiuMeng YangYe WeiYijiao ChenMeiling JiGuosong ChenWenju ChangJianmin Xu
Published in: Journal of translational medicine (2022)
Our study revealed a potential tumor-suppressive role of miR-500a-3p in CRC, specifically targeting CDK6 and inhibiting cancer cell proliferation and aerobic glycolysis, which may provide new insights into novel prognostic biomarkers and therapeutic targets for CRC.
Keyphrases
  • cell cycle
  • cell proliferation
  • signaling pathway
  • high intensity
  • papillary thyroid
  • single cell
  • squamous cell
  • cancer therapy
  • pi k akt
  • young adults
  • human health
  • climate change